Germany· DE-A57-9f393885a7680797

Rekurin

A medicinal product containing colchicum autumnale d3, artemisia abrotanum d3, bryonia dil. d3, registered in Germany by Cesra Arzneimittel Gmbh And Co. Kg.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedRekurinATC—REGISTER NO.DE-A57-9f393885a76807…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Active substance
Colchicum Autumnale D3, Artemisia Abrotanum D3, Bryonia Dil. D3
Manufacturer
Cesra Arzneimittel Gmbh And Co. Kg
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ecb9954f-0e11-4a4d-8f21-cb13526858d3
GET /v1/drugs/ecb9954f-0e11-4a4d-8f21-cb13526858d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Colchicum Autumnale D3, Artemisia Abrotanum D3, Bryonia Dil. D3",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about colchicum autumnale d3, artemisia abrotanum d3, bryonia dil. d3.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.